Description

ZOPISIGN 7.5 is a reliable, clinically approved oral sleep aid formulated with Zopiclone 7.5mg, commonly prescribed for the short-term treatment of insomnia, including difficulty falling asleep, frequent night-time awakenings, and early morning waking.

As part of the Z-drug class, Zopiclone acts on GABA receptors in the brain to produce calming effects and regulate the sleep-wake cycle without the stronger residual effects associated with older sedatives like benzodiazepines.

Key Uses:

• Short-term management of acute or transient insomnia

• Treatment for stress-induced or travel-related sleep disorders

• Safe for adult patients under medical supervision

ZOPISIGN 7.5 usually begins working within 20–30 minutes and supports 6–8 hours of restful sleep.

Manufactured in accordance with WHO-GMP, ISO 9001:2015, and FDA-export compliance standards, ZOPISIGN 7.5 meets the quality expectations of regulated and semi-regulated markets.

Presented by BLUEPILL EXPRESS, a trusted global exporter of premium CNS pharmaceuticals.

• Active Ingredient: Zopiclone 7.5mg

• Dosage Form: Oral Tablet

• Therapeutic Class: Sedative-Hypnotic (Non-Benzodiazepine)

• Primary Use: Insomnia Treatment

• Onset of Action: 20–30 minutes

• Effect Duration: Up to 8 hours

• Certifications: WHO-GMP | ISO 9001:2015 | FDA-export compliant

• Exporter: BLUEPILL EXPRESS

How to Use:

Take one tablet orally just before bedtime. Use only under the supervision of a healthcare professional. Do not exceed the prescribed duration (typically 7–14 days) to avoid dependency. Avoid driving or operating machinery after use.